Key signaling pathways enriched in the analysis include Pathways in cancer, PI3K/Akt signaling, EGFR tyrosine kinase inhibitor resistance, endocrine resistance, and central carbon metabolism in cancer. This evidence concerns the gene AKT1 and cancer.